Apollo AyurVAID, a pioneer in precision Ayurveda, is expanding into the Ayurveda products segment. This strategic move aims ...

Apollo AyurVAID, acquired by Apollo Hospitals, sees rapid growth, plans expansion to new markets, aims for revenue milestone, ...

Continues to build a full-stack Ayurveda enterprise with focus on comprehensive precision Ayurveda care and integrative medicine for patients across various clinical conditions • Launches 50 SKUs ...

Apollo AyurVAID is venturing into the Ayurveda product market with a Rs 15 crore investment, aiming to reach Rs 500 crore revenue in five years. This move complements their existing care model and ...

Apollo AyurVAID launches Ayurveda product line with ₹15 crore investment, aiming for ₹500 crore revenue in 5 years. Expands ...

Apollo AyurVAID, one of India's largest Ayurvedic hospital chains, targets 1,000 beds and Rs 500 crore turnover by 2028, as demand for Ayurvedic treatments rises ...

AyurVAID Hospitals Receives QAI Accreditation for its Transition Care Centre QAI is an institutional member of the International Society for Quality in Health Care (ISQua) with a vision to create ...

Apollo Hospitals Enterprise Ltd. (AHEL), pioneers in healthcare and India’s first multi-speciality chain of hospitals, has announced the execution of definitive agreements to acquire a 60 per cent ...

Apollo Hospitals Enterprise Ltd on Thursday announced the execution of definitive agreements to acquire a 60 percent stake in the leading classical Ayurveda hospital chain, AyurVAID, in a ...

Universal Ayurvaid, Nagpur Learn about Universal Ayurvaid in Nagpur, Maharashtra.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location.

Apollo AyurVAID, acquired by Apollo Hospitals, sees rapid growth, plans expansion to new markets, aims for revenue milestone, and explores international markets.

Apollo Hospitals has announced the execution of definitive agreements to acquire a 60 per cent stake in Ayurveda hospital chain AyurVAID in a combination of primary and secondary capital infusion ...